Lexicon is evaluating the safety and efficacy of sotagliflozin in patients with both obstructive and non-obstructive hypertrophic cardiomyopathy (HCM) Pivotal Phase 3 clinical trial is actively ...

If you have cancer, you expect to see an oncologist, but if you have heart failure you may or may not see a cardiologist.

People with irregular sleep schedules had a 26% higher risk of major cardiovascular events, even if they got the recommended ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

If you have cancer, you expect to see an oncologist, but if you have heart failure you may or may not see a cardiologist.

If you have cancer, you expect to see an oncologist, but if you have heart failure you may or may not see a cardiologist. According to research ...

CellProthera will tech transfer to CELLforCURE by SEQENS this year, with plans to produce clinical batches starting in 2026.

CellProthera says it chose CELLforCURE by SEQENS as its CDMO for the quality of its infrastructure, equipment, and expertise of its team.

Recombinant zoster vaccine reduces all-cause mortality in patients with immune-mediated inflammatory diseases receiving Janus ...

Rocket Pharmaceuticals has shared early data from three patients that tie its gene therapy for an inherited heart disease to ...

Specifically, rates of falls, fractures, glaucoma, and cognitive changes were comparable across both timing strategies. The ...